Related Experiment Video
Updated: Jul 7, 2026
05:46
A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
3.6K
Exploring the molecular mechanisms underlying intervertebral disc degeneration by analysing multiple datasets
Longquan Lin1, Da Li2, Gangfeng Cai3
1Department of Orthopaedics, The 910th Hospital of PLA, Quanzhou, 362000, China. 467796153@qq.com.
Scientific Reports
|April 27, 2025
Summary
This study identified four key genes (COL6A2, DCXR, GLRX, PDGFRB) and immune cell changes in intervertebral disc degeneration (IVDD). Potential drugs like Abt-751 may reverse IVDD progression, offering new therapeutic avenues.
Area of Science:
- Genetics
- Immunology
- Pharmacology
Background:
- Intervertebral disc degeneration (IVDD) is a complex condition with poorly understood genetic and immune underpinnings.
- Identifying key molecular players and therapeutic targets is crucial for effective clinical treatment.
Purpose of the Study:
- To explore genetic characteristics and immune cell infiltration in IVDD using multi-dataset analysis.
- To predict potential therapeutic drugs for IVDD and provide a theoretical basis for clinical application.
Main Methods:
- Downloaded and analyzed gene expression profile data from GEO datasets (GSE70362, GSE186542, GSE245147).
- Identified hub genes via differential expression analysis, functional annotation (GO, KEGG), and Mendelian randomization.
- Assessed immune cell infiltration using GSEA and GSVA, and predicted drugs using the Connectivity Map database.
Main Results:
- Identified four key differentially expressed hub genes: COL6A2, DCXR, GLRX, and PDGFRB.
- Revealed immune cell activation (NK cells, macrophages, eosinophils) and suppression (mast cells, T cells) in IVDD.
- Signaling pathways including glycolysis, oxidative phosphorylation, cholesterol regulation, and heme metabolism are implicated.
Conclusions:
- COL6A2, DCXR, GLRX, and PDGFRB are identified as key genes in IVDD pathogenesis.
- Drugs like Abt-751 show potential for alleviating or reversing IVDD progression.
- These findings offer new directions for mechanistic studies and therapeutic strategies for IVDD patients.
Keywords:
Drug–gene interaction analysisHub geneImmune inflammationIntervertebral disc degenerationMultidataset analysisMore Related Videos
Related Concept Videos
01:29Herniated Intervertebral Disc l: Introduction
Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...